News for 'drug development'

Modi's day: Meetings with NSA, Musk, bilateral with Trump, and dinner

Modi's day: Meetings with NSA, Musk, bilateral with Trump, and dinner

Rediff.com13 Feb 2025

Prime Minister Narendra Modi is set to hold bilateral meetings with US President Donald Trump and other prominent American personalities during his two-day visit to the United States.

Budget Prepares For Rise In Cancer Cases

Budget Prepares For Rise In Cancer Cases

Rediff.com3 Feb 2025

Do we have enough trained oncologists and medical professionals in India to man these over 4,500 beds in the public sector?

BSE 100 companies boost R&D, innovation challenges persist

BSE 100 companies boost R&D, innovation challenges persist

Rediff.com13 Oct 2024

Research and development (R&D) spending by BSE 100 companies has grown steadily, rising from 0.89 per cent of revenue in FY20 to 1.32 per cent in FY24, averaging around 1 per cent over the period in-between, according to data compiled from Bloomberg and company annual reports. Also, these companies more than doubled their R&D spending in absolute terms over these five years: From Rs 25,041 crore to Rs 63,072 crore. While this reflects a prioritisation of innovation, corporate R&D investment remains relatively conservative.

Who will succeed Biren Singh as Manipur CM?

Who will succeed Biren Singh as Manipur CM?

Rediff.com10 Feb 2025

Manipur Chief Minister N Biren Singh resigned on Sunday, following months of ethnic violence in the state. BJP leaders have begun closed-door meetings to decide the next course of action. The opposition welcomed Singh's resignation, while the BJP hopes the move will help restore peace in the region.

Budget 2025: More Jobs Via Thriving Farms and MSME Growth

Budget 2025: More Jobs Via Thriving Farms and MSME Growth

Rediff.com4 Feb 2025

The most striking features of this Budget was its focus on simplification and improving the ease of doing business in India, asserts Kaku Nakhate.

Hetero launches generic COVID-19 drug at Rs 59 per tablet

Hetero launches generic COVID-19 drug at Rs 59 per tablet

Rediff.com29 Jul 2020

Favivir is the second drug developed by Hetero after Covifor (Remdesivir) used in the treatment of COVID-19.

Avoid Mini Trade Deal With US

Avoid Mini Trade Deal With US

Rediff.com13 Feb 2025

The Budget has given signals that India is sensitive to the US needs and willing to walk the extra mile, but if need be, we should respond in equal measure as a sovereign nation, notes Ajay Srivastava.

India can develop cheap drugs: CII

India can develop cheap drugs: CII

Rediff.com20 Sep 2004

'Tariffs will hurt insurance, patients and everyone'

'Tariffs will hurt insurance, patients and everyone'

Rediff.com10 Feb 2025

After registering a net profit of Rs 25.1 crore in Q3FY25 and consolidated revenues growing by 7 per cent on a like-for-like basis, Siddharth Mittal, chief executive officer (CEO) and managing director, Biocon, told Sohini Das/Business Standard in a virtual interaction that local manufacturing in the US is a trade off between cost and qualifying to do business there.

Parents, Equip Your Child For A Changing World

Parents, Equip Your Child For A Changing World

Rediff.com19 Dec 2024

'Make your child solve his/her problems on his/her own. Let the child see parenting as a partnership between you and your child.'

Piramal Life may develop TB drug

Piramal Life may develop TB drug

Rediff.com17 Sep 2008

Piramal Life Sciences may become the first company to successfully develop a tuberculosis drug whose leads isolated from the living organisms found in ice brought from the Antarctica region. "(Our) scientists have identified additional leads that will help develop drugs to treat tuberculosis and other infections," revealed Swati Piramal, director, Nicholas Piramal.

India hopes for temporary tariff waiver as US official comes calling

India hopes for temporary tariff waiver as US official comes calling

Rediff.com24 Mar 2025

India and the United States will finalize the contours, schedule of negotiations, and terms of reference for a proposed bilateral trade agreement (BTA) during a three-day meeting beginning Tuesday. The agreement is expected to be finalized in two tranches, with the first phase focusing on goods trade. The US team, led by Assistant US Trade Representative for South and Central Asia Brendan Lynch, will be in India from March 25-29 to discuss the agreement. Both countries are aiming to conclude the first phase of the agreement by fall 2025.

Biren Singh resigns as Manipur CM, assembly session scrapped

Biren Singh resigns as Manipur CM, assembly session scrapped

Rediff.com9 Feb 2025

Amidst rumblings within the state Bharatiya Janata Party seeking a change of leadership in strife-torn Manipur, Chief Minister N Biren Singh on Sunday tendered his resignation to Governor Ajay Kumar Bhalla at the Raj Bhavan in Imphal.

There will be no winner: Xi's warning to Trump

There will be no winner: Xi's warning to Trump

Rediff.com10 Dec 2024

Gearing up for Trump 2.0 era, Chinese President Xi Jinping on Tuesday cautioned there will be no winner in a tariff or tech wars between China and the United States and vowed that Beijing would firmly safeguard its interests.

USTR Report Intensifies Trade Tensions With India

USTR Report Intensifies Trade Tensions With India

Rediff.com2 Apr 2025

The US Trade Representative noted that India's average applied tariff rate stood at 17% per cent, the highest of any major world economy.

Of Trump's reciprocal tariffs and trade deals

Of Trump's reciprocal tariffs and trade deals

Rediff.com14 Feb 2025

Of Trump's reciprocal tariffs and trade deals

Despite short-term blip, Sun Pharma remains favourite among investors

Despite short-term blip, Sun Pharma remains favourite among investors

Rediff.com28 Dec 2024

Around six weeks ago, Sun Pharmaceutical Industries, India's largest drugmaker, suffered a setback, which led to a selloff in the share. The US District Court of New Jersey granted Incyte's request for a preliminary injunction against Sun Pharma's launch of Leqselvi, a drug that treats alopecia.

Nicholas Piramal develops drug leads from Antarcti

Nicholas Piramal develops drug leads from Antarcti

Rediff.com29 Jun 2007

Indian drug major Nicholas Piramal India Ltd is likely to be among the first pharmaceutical companies worldwide to develop drugs isolated from the flora and fauna of Antarctica.

Budget 2025: Defence Must Be The Priority

Budget 2025: Defence Must Be The Priority

Rediff.com31 Jan 2025

'The first and most basic responsibility of any government is to protect its people from external threats and internal harm.' 'Budget 2025-2026 has to focus on meeting this responsibility,' asserts R Jagannathan.

How 'Guru Gary' is using cricket to keep slum kids away from drugs

How 'Guru Gary' is using cricket to keep slum kids away from drugs

Rediff.com15 Feb 2024

Notorious for drugs and crime and afflicted by large-scale poverty, the Khayelitsha township in Cape Town is better known for being one of the biggest slums on the planet. But World Cup-winning coach Gary Kirsten is attempting to change the image for good through cricket.

The Coming Dementia Epidemic

The Coming Dementia Epidemic

Rediff.com20 Dec 2024

Around 7.4 per cent of Indians aged 60 and above are affected by dementia. This number is expected to rise from the current 8.8 million to 17 million by 2036, marking a 97 per cent increase.

Blue Economy Needs Strong Navy Protection

Blue Economy Needs Strong Navy Protection

Rediff.com7 Jan 2025

Naval assets take years to build, and therefore, not only is futuristic force planning essential, but indigenous projects must also be put into the pipeline, technologies developed and contracts for assets signed regularly so that the Indian Navy always remains a future-focussed force, asserts Vice Admiral Biswajit Dasgupta (retd).

Idiopathic Pulmonary Fibrosis: What Killed Ustad Zakir Hussain

Idiopathic Pulmonary Fibrosis: What Killed Ustad Zakir Hussain

Rediff.com17 Dec 2024

'It's almost like the tissue of the lung has a cancer spreading to it, which is causing scarring and rapidly progresses.'

US cop who struck and killed Indian student with patrol car fired

US cop who struck and killed Indian student with patrol car fired

Rediff.com7 Jan 2025

The development comes months after another Seattle police officer Daniel Auderer was fired following his insensitive comments and laughter after Kandula's death.

'I've Not Backstabbed Anybody'

'I've Not Backstabbed Anybody'

Rediff.com18 Nov 2024

'They are attacking my wife; they are attacking our 13-month-old daughter. They are saying that I do drugs.' 'I'm giving an open challenge to Mr Nawab Malik and Ms Sana Malik let's go to the labs and let's do the medical test of our family and your family.'

Ranbaxy's malaria drug awaits international nod

Ranbaxy's malaria drug awaits international nod

Rediff.com14 Nov 2011

Health experts attribute this to the absence of international approval for the drug. About 90 per cent of malaria infections are reported from sub-Saharan Africa.

Pushpa 2 stampede row: CM vows to back Telugu cinema

Pushpa 2 stampede row: CM vows to back Telugu cinema

Rediff.com26 Dec 2024

Declaring the Telangana government's support to the Telugu film industry, Chief Minister A Revanth Reddy on Thursday said the former would take steps to make Hyderabad a destination for international film shootings.

Anti-drone unit to be set up to tackle UAV menace on borders: Shah

Anti-drone unit to be set up to tackle UAV menace on borders: Shah

Rediff.com8 Dec 2024

Union Home Minister Amit Shah has announced that India will soon create a comprehensive anti-drone unit to secure its borders. He highlighted the increasing threat posed by drones, especially along the India-Pakistan border, and emphasized a 'whole of government' approach to tackle this issue. Shah also spoke about the ongoing Comprehensive Integrated Border Management System (CIBMS) and the Modi government's Vibrant Village Programme, which aims to develop and integrate the population of northern borders.

Sitharaman turns middle class hero with tax cuts, reforms

Sitharaman turns middle class hero with tax cuts, reforms

Rediff.com1 Feb 2025

"The new structure will substantially reduce taxes on the middle class and leave more money in their hands, boosting household consumption, savings and investment," Sitharaman said presenting what was dubbed as 'reformist' budget for the next fiscal in Lok Sabha.

President's Rule In Manipur: Need Of The Hour

President's Rule In Manipur: Need Of The Hour

Rediff.com13 Feb 2025

The solution to Manipur's problems lies in the government giving concessions to Meitis in jobs and education and to accept autonomy for the tribal dominated areas inhibited by the Kukis, suggests Colonel Anil A Athale (retd).

A Breakthrough In Nipah Virus Research

A Breakthrough In Nipah Virus Research

Rediff.com5 Jun 2024

This will also help test the effectiveness of preventing the entry of Nipah in target cells.

Nicholas in drug deal with Eli Lilly

Nicholas in drug deal with Eli Lilly

Rediff.com13 Jan 2007

Domestic pharma firm inks first-of-its-kind pact.

Tough Fight For Mumbai's 'Muslim Leader'

Tough Fight For Mumbai's 'Muslim Leader'

Rediff.com18 Nov 2024

'In this assembly election, Muslims here will vote for one who works, but also one who safeguards their identity.' 'Their existence is more important they feel, than a faulty light meter. So yes, a Muslim representative will make a difference.'

Ranbaxy to develop prostrate cancer drug

Ranbaxy to develop prostrate cancer drug

Rediff.com24 Jun 2004

Ranbaxy said on Thursday that it has signed an exclusive licensing agreement with US-based Atrix Laboratories to develop and market prostrate cancer drug Eligard in India.

Jt drugs controller waives trial of Biocon drug; arrested

Jt drugs controller waives trial of Biocon drug; arrested

Rediff.com21 Jun 2022

The CBI has arrested Joint Drugs Controller S Eswara Reddy for allegedly receiving a Rs 4 lakh bribe to waive the phase three clinical trial of the Insulin Aspart injection, a product of Biocon Biologics under development to manage Type 1 and Type 2 diabetes, officials said on Tuesday. Biocon Biologics is a subsidiary of the Kiran Mazumdar Shaw-led Biocon. The company has denied allegations. The agency has also arrested Dinesh Dua, director at Synergy Network India Private Limited, who was allegedly giving Reddy a bribe, they said.

Hyderabad firm develops next-gen XBB1.5 Covid vax, awaits trial nod

Hyderabad firm develops next-gen XBB1.5 Covid vax, awaits trial nod

Rediff.com28 Dec 2023

As of now, Gennova Biopharmaceuticals has launched a vaccine, Gemcovac-OM, which is based on the Omicron variant.

Ranbaxy to develop anti-malarial drug

Ranbaxy to develop anti-malarial drug

Rediff.com19 May 2003

Ranbaxy Laboratories has signed an agreement with Geneva's Medicines for Malaria Venture for developing synthetic peroxide anti-malarial drug

J-K: 5 cops, teacher sacked for narco-terror links

J-K: 5 cops, teacher sacked for narco-terror links

Rediff.com3 Aug 2024

The Jammu and Kashmir administration on Saturday sacked six government employees, including five policemen, for their 'deep involvement in anti-national activities', officials said.

Assembly can't restore Art 370, don't get misled by false promises: Azad

Assembly can't restore Art 370, don't get misled by false promises: Azad

Rediff.com29 Sep 2024

Addressing a series of election rallies in support of his party's candidates in Jammu on the last day of campaigning, Azad voiced concerns over the promises made by various political parties regarding the return of Article 370 and said these promises are not grounded in reality.

Chhattisgarh will be Maoist-free by Mar 2026: Amit Shah

Chhattisgarh will be Maoist-free by Mar 2026: Amit Shah

Rediff.com15 Dec 2024

Union Home Minister Amit Shah has declared that Chhattisgarh will be free from the menace of Naxalism by March 31, 2026. He stated that the Centre and the state government are committed to eradicating Naxalism, highlighting the significant achievements of the Chhattisgarh police in the last year. Shah also appealed to Naxalites to surrender and join the mainstream, emphasizing the government's rehabilitation policy. He further praised the Chhattisgarh police's efforts in curbing organized crime and narcotics.